Clinical trials are volunteer-based studies that give researchers insights into diseases, so they can develop effective treatments and medications.
PDF Version – Strategic Plan Fiscal Years 2020–2024 (1171 KB) Table of Contents DIRECTOR’S MESSAGE EXECUTIVE SUMMARY INTRODUCTION, MISSION, AND STRUCTURE Introduction Mission and Statutory Authority NIAMS Organizational Structure CROSS-CUTTING SCIENTIFIC THEMES Precision Medicine for Arthritis and Musculoskeletal and Skin Diseases Shared Mechanisms in Health and Among Diseases Patient-Centric Approaches
Anyone, an individual or an organization, can donate to the NIAMS. The NIAMS is federally funded and not a fundraising organization; but, the U.S. Congress authorizes NIAMS to accept donations and bequests to support the scientific mission of the Institute. Donations to NIAMS are deposited in a NIAMS “Gift Fund”
Did you know that you can participate in clinical research? Whether you’re healthy or sick, young or old, male or female, you’re probably eligible to participate in some type of clinical study. Maybe you or a loved one has an illness, and you’d like to help scientists find a treatment or cure. If you’re healthy, you can help researchers learn more about how the body works or how sickness can be prevented. Clinical research, also known as clinical studies or clinical trials, offers hope for many people, because it helps to find better treatments. Clinical trials are at the heart
2019 NIAMS Coalition Meeting Photos. Welcome and Announcements The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) held its seventh biennial Coalition Outreach and Education Meeting: Creating Connections for Science, on October 16, 2019 at the Natcher Conference Center on the main National Institutes of Health (NIH) campus in Bethesda, Md. The NIAMS Coalition is an independent group of more than 90 professional and voluntary organizations interested in programs that are under the purview of the NIAMS. More than 50 representatives from over 40 Coalition organizations attended the meeting. Nancy Garrick, Ph.D., chief of the Science Communications and